WoundScribe AI
Share
X Facebook WhatsApp Email

How to Launch a Wound Care Product Inside the WoundScribe Catalog in 30 Days

product

Published

A 30-day onboarding playbook for skin substitute and wound care brands: from kickoff call to point-of-care placement inside WoundScribe.

You've signed the partnership. Now the question is: how fast can your product start surfacing at the moment clinicians choose treatments? Here's the 30-day path from kickoff to live placement inside WoundScribe.

Week 1 — Kickoff and product intake

  1. Kickoff call. Your team meets with WoundScribe onboarding to align on indications, target wound phenotypes, and preferred billing codes.
  2. Product intake packet. You submit IFU, approved indications, HCPCS/CPT codes, clinical rationale bullets, and any supporting evidence.
  3. Use-case matching draft. WoundScribe drafts the initial matching rules — which wound phenotypes, trajectories, and patient contexts should surface your product.

Week 2 — Configuration and clinical review

  1. Matching rules review. Your medical or clinical affairs lead reviews the draft and refines edge cases (e.g., contraindications, reapplication windows).
  2. Billing code mapping. Codes are attached to each indication so clinicians see the correct reimbursement path at the point of care.
  3. Education snippets. Short, on-label rationale text is written and approved for in-workflow display.

Week 3 — Staging and QA

  1. Staging environment. Your product goes live in a WoundScribe staging tenant. You see exactly what a clinician sees when their patient's wound matches your indication.
  2. Simulated cases. WoundScribe runs simulated patient trajectories to confirm the product surfaces correctly — and does not surface where it shouldn't.
  3. Sign-off. Your team signs off on placement, wording, and codes.

Week 4 — Go live and monitor

  1. Production release. Your product is live in the WoundScribe AI-powered EMR for wound care across participating clinicians.
  2. Baseline metrics. WoundScribe captures baseline surfacing volume, wound-type mix, and reapplication patterns.
  3. First review call. At day 30, you review usage data, clinician feedback, and any refinements for the next cycle.

See where launch fits in the broader solutions overview.